Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals
View ORCID ProfileCarolina Lucas, Chantal B. F. Vogels, Inci Yildirim, Jessica E. Rothman, Peiwen Lu, Valter Monteiro, Jeff R. Gelhausen, Melissa Campbell, View ORCID ProfileJulio Silva, Alexandra Tabachikova, M. Catherine Muenker, Mallery I. Breban, Joseph R. Fauver, Subhasis Mohanty, Jiefang Huang, Yale SARS-CoV-2 Genomic Surveillance Initiative, Claire Pearson, Anthony Muyombwe, Randy Downing, Jafar Razeq, Mary Petrone, Isabel Ott, Anne Watkins, Chaney Kalinich, Tara Alpert, Anderson Brito, Rebecca Earnest, Steven Murphy, Caleb Neal, Eva Laszlo, Ahmad Altajar, Irina Tikhonova, Christopher Castaldi, Shrikant Mane, Kaya Bilguvar, Nicholas Kerantzas, David Ferguson, Wade Schulz, Marie Landry, David Peaper, Albert C. Shaw, Albert I. Ko, Saad B. Omer, Nathan D. Grubaugh, View ORCID ProfileAkiko Iwasaki
doi: https://doi.org/10.1101/2021.07.14.21260307
Carolina Lucas
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
Chantal B. F. Vogels
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Inci Yildirim
3Department of Pediatric, Section of Infectious Diseases and Global Health; Yale University School of Medicine, New Haven, CT, USA
4Yale Institute for Global Health, Yale University, New Haven, CT, USA
Jessica E. Rothman
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Peiwen Lu
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
Valter Monteiro
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
Jeff R. Gelhausen
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
5Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA
Melissa Campbell
6Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
Julio Silva
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
Alexandra Tabachikova
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
M. Catherine Muenker
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Mallery I. Breban
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Joseph R. Fauver
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Subhasis Mohanty
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
6Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
Jiefang Huang
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
6Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
Claire Pearson
11Connecticut State Department of Public Health, Rocky Hill, CT 06067, USA
Anthony Muyombwe
11Connecticut State Department of Public Health, Rocky Hill, CT 06067, USA
Randy Downing
11Connecticut State Department of Public Health, Rocky Hill, CT 06067, USA
Jafar Razeq
11Connecticut State Department of Public Health, Rocky Hill, CT 06067, USA
Mary Petrone
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Isabel Ott
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Anne Watkins
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Chaney Kalinich
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Tara Alpert
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Anderson Brito
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Rebecca Earnest
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Steven Murphy
12Murphy Medical Associates, Greenwich, CT 06830, USA
Caleb Neal
12Murphy Medical Associates, Greenwich, CT 06830, USA
Eva Laszlo
12Murphy Medical Associates, Greenwich, CT 06830, USA
Ahmad Altajar
12Murphy Medical Associates, Greenwich, CT 06830, USA
Irina Tikhonova
13Yale Center for Genome Analysis, Yale University, New Haven, CT, 06510, USA
Christopher Castaldi
13Yale Center for Genome Analysis, Yale University, New Haven, CT, 06510, USA
Shrikant Mane
13Yale Center for Genome Analysis, Yale University, New Haven, CT, 06510, USA
Kaya Bilguvar
13Yale Center for Genome Analysis, Yale University, New Haven, CT, 06510, USA
Nicholas Kerantzas
14Department of Laboratory Medicine, Yale New Haven Hospital, CT 06510, USA
David Ferguson
15Center for Outcomes Research and Evaluation, Yale New Haven Hospital, CT 06510, USA
Wade Schulz
15Center for Outcomes Research and Evaluation, Yale New Haven Hospital, CT 06510, USA
16Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA
Marie Landry
17Departments of Laboratory Medicine and Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
David Peaper
17Departments of Laboratory Medicine and Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
Albert C. Shaw
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
6Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
Albert I. Ko
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
6Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
Saad B. Omer
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
4Yale Institute for Global Health, Yale University, New Haven, CT, USA
6Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
Nathan D. Grubaugh
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
7Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA
Akiko Iwasaki
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
8Howard Hughes Medical Institute, Chevy Chase, MD, USA
Data Availability
All the background information for HCWs participants in this study are included in Source Data Figure 1. All the genome information for SARS-CoV-2 variants used in this study are available in Source Data Figure 2, and the aligned consensus genomes are available on GitHub (https://github.com/grubaughlab/paper_2021_Nab-variants). Additional correspondence and requests for materials should be addressed to the corresponding author (A.I).
Posted July 18, 2021.
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals
Carolina Lucas, Chantal B. F. Vogels, Inci Yildirim, Jessica E. Rothman, Peiwen Lu, Valter Monteiro, Jeff R. Gelhausen, Melissa Campbell, Julio Silva, Alexandra Tabachikova, M. Catherine Muenker, Mallery I. Breban, Joseph R. Fauver, Subhasis Mohanty, Jiefang Huang, Yale SARS-CoV-2 Genomic Surveillance Initiative, Claire Pearson, Anthony Muyombwe, Randy Downing, Jafar Razeq, Mary Petrone, Isabel Ott, Anne Watkins, Chaney Kalinich, Tara Alpert, Anderson Brito, Rebecca Earnest, Steven Murphy, Caleb Neal, Eva Laszlo, Ahmad Altajar, Irina Tikhonova, Christopher Castaldi, Shrikant Mane, Kaya Bilguvar, Nicholas Kerantzas, David Ferguson, Wade Schulz, Marie Landry, David Peaper, Albert C. Shaw, Albert I. Ko, Saad B. Omer, Nathan D. Grubaugh, Akiko Iwasaki
medRxiv 2021.07.14.21260307; doi: https://doi.org/10.1101/2021.07.14.21260307
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals
Carolina Lucas, Chantal B. F. Vogels, Inci Yildirim, Jessica E. Rothman, Peiwen Lu, Valter Monteiro, Jeff R. Gelhausen, Melissa Campbell, Julio Silva, Alexandra Tabachikova, M. Catherine Muenker, Mallery I. Breban, Joseph R. Fauver, Subhasis Mohanty, Jiefang Huang, Yale SARS-CoV-2 Genomic Surveillance Initiative, Claire Pearson, Anthony Muyombwe, Randy Downing, Jafar Razeq, Mary Petrone, Isabel Ott, Anne Watkins, Chaney Kalinich, Tara Alpert, Anderson Brito, Rebecca Earnest, Steven Murphy, Caleb Neal, Eva Laszlo, Ahmad Altajar, Irina Tikhonova, Christopher Castaldi, Shrikant Mane, Kaya Bilguvar, Nicholas Kerantzas, David Ferguson, Wade Schulz, Marie Landry, David Peaper, Albert C. Shaw, Albert I. Ko, Saad B. Omer, Nathan D. Grubaugh, Akiko Iwasaki
medRxiv 2021.07.14.21260307; doi: https://doi.org/10.1101/2021.07.14.21260307
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)